ALZN Alzamend Neuro Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ALZN

Price (delayed)

$0.72

Market cap

$4.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.87

Enterprise value

$4.66M

Highlights
ALZN's EPS is up by 25% year-on-year and by 19% since the previous quarter
ALZN's net income is up by 20% year-on-year and by 18% since the previous quarter
The quick ratio has shrunk by 97% YoY but it has increased by 40% QoQ
ALZN's equity has dropped by 173% year-on-year and by 59% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://alzamend.com/
Peers: OCX OGEN OLMA OMER

Key stats

What are the main financial stats of ALZN
Market
Shares outstanding
6.87M
Market cap
$4.94M
Enterprise value
$4.66M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$12.39M
EBITDA
-$12.35M
Free cash flow
-$9.23M
Per share
EPS
-$1.87
Free cash flow per share
-$1.31
Book value per share
-$0.6
Revenue per share
$0
TBVPS
$0.11
Balance sheet
Total assets
$782,636
Total liabilities
$4.57M
Debt
$0
Equity
-$4.26M
Working capital
-$3.23M
Liquidity
Debt to equity
0
Current ratio
0.16
Quick ratio
0.07
Net debt/EBITDA
0.02
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-481.2%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALZN stock price

How has the Alzamend Neuro stock price performed over time
Intraday
-7.69%
1 week
-19.55%
1 month
-22.58%
1 year
-91.86%
YTD
-19.1%
QTD
-28%

Financial performance

How have Alzamend Neuro's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$12.39M
Net income
-$12.4M
Gross margin
N/A
Net margin
N/A
ALZN's net income is up by 20% year-on-year and by 18% since the previous quarter
ALZN's operating income is up by 20% year-on-year and by 18% since the previous quarter

Growth

What is Alzamend Neuro's growth rate over time

Valuation

What is Alzamend Neuro stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ALZN's EPS is up by 25% year-on-year and by 19% since the previous quarter
ALZN's equity has dropped by 173% year-on-year and by 59% since the previous quarter

Efficiency

How efficient is Alzamend Neuro business performance
ALZN's ROA is down by 43% from the previous quarter

Dividends

What is ALZN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALZN.

Financial health

How did Alzamend Neuro financials performed over time
Alzamend Neuro's total assets is 83% less than its total liabilities
The quick ratio has shrunk by 97% YoY but it has increased by 40% QoQ
The current ratio has plunged by 95% YoY and by 24% from the previous quarter
ALZN's debt is 100% greater than its equity
ALZN's equity has dropped by 173% year-on-year and by 59% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.